Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $7.6650 (0.39%) ($7.6650 - $7.6650) on Fri. Jul. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.66% (three month average) | RSI | 60 | Latest Price | $7.6650(0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.4% a day on average for past five trading days. | Weekly Trend | IOVA advances 4.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) GLD(45%) XBI(26%) GDXJ(18%) IGOV(18%) SLV(18%) | Factors Impacting IOVA price | IOVA will decline at least -2.83% in a week (0% probabilities). XLU(-26%) UUP(-24%) XME(-22%) VYM(-22%) XLP(-20%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.83% (StdDev 5.66%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.87(-2.6%) | 10 Day Moving Average | $7.92(-3.22%) | 20 Day Moving Average | $7.62(0.59%) | To recent high | -15.8% | To recent low | 42.9% | Market Cap | $1.122b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |